The $260B Denial Problem Demands Better Automation Now
Amperos Lands Bessemer VC to Scale Denial Management Platform
Amperos, a denial management startup, secured funding from Bessemer Venture Partners to expand its platform for hospitals and health systems struggling with claim denials. The company targets what Bessemer frames as a $260B+ annual problem in the U.S. healthcare system—claims rejected or delayed due to incomplete documentation, coding errors, and payor-specific requirements that bog down revenue cycle teams.
The Deal
Bessemer Venture Partners led the investment round, though the specific amount and valuation remain undisclosed. The funding will support product development, go-to-market expansion, and hiring across engineering and customer success. Amperos has positioned itself as a software vendor focused on automating denial tracking, root cause analysis, and appeal workflows—work that typically consumes significant manual labor in hospital billing departments.
What It Means for RCM
- Denial rework pressure easing slightly: Another well-funded player entering the denial space signals that VCs see a real, repeatable TAM. For billing teams, this could mean faster iteration cycles and more competitive pricing as the market matures—good news if you're evaluating platforms.
- Automation becoming table stakes: Denial management is moving from spreadsheet-and-manual-review to software-driven categorization and predictive flagging. Teams that don't adopt some form of automation risk falling further behind on denial rates and days in AR.
- Data standardization opportunity: As more vendors compete in this space, pressure will build for standardized denial reason codes and faster feedback loops from payors. That benefits everyone's workflow, though integration burden on your IT team will likely increase.
Market Context
Denial management has been a perennial underinvested area of the healthcare revenue cycle, despite the massive financial impact. Most hospitals still rely on cobbled-together workflows combining manual review, EHR reports, and payor portals. Bessemer's backing suggests investor conviction that software can meaningfully move the needle on denial prevention and appeal success rates—categories that have historically resisted automation. Other vendors in the denial space include Optum's denial management tools and a handful of smaller platforms, but market consolidation and specialization are likely ahead.
For billing operations leaders, the message is clear: if your denial management process still relies heavily on human review and payor phone calls, your competitive position is weakening. Amperos and similar platforms will gradually become standard in mid-to-large hospital networks within the next 18–24 months.
Find Exact Policy Language with Axlow
Navigating payor policy changes requires access to the most current requirements. Axlow provides instant search across all major payor policies, including prior authorization criteria, coverage guidelines, and appeals procedures.
Free Daily RCM Intelligence
Denial trends, payer policy moves, vendor intel — delivered every morning. Free.